news
-
NAVIPP at the European Congress of Virology 2025
NAVIPP was proud to be represented at the European Congress of Virology 2025, held in the beautiful setting of Cavtat and Dubrovnik, Croatia. Audrey Richard (ERINHA) introduced the project to an audience of leading virology experts, highlighting NAVIPP’s ambition to develop broad-spectrum antivirals as a key pillar of European pandemic preparedness. Through its dual-track approach — combining strategic innovation and practical readiness — NAVIPP is…
-
NAVIPP project poised to contribute to WHO’s new R&D Blueprint for Epidemics
WHO’s New Pathogens Prioritization Framework In 2015, the World Health Organization (WHO), at the request of almost 200 member states, developed its first Research & Development (R&D) Blueprint for Action to Prevent Epidemics focusing on a number of specific severe infectious diseases for which no medical countermeasures (MCMs) were available. Launched for the first time…
-
NAVIPP Kick-Off Meeting on March 20-21, 2024 in Paris
The NAVIPP Kick-Off Meeting aimed to set the stage for the project’s strategic and operational framework, fostering collaboration among partners to address epidemic and pandemic viral threats through research and innovation. NAVIPP represents a collaborative effort among esteemed international research institutions, pharmaceutical entities, and public health organizations. At its core, NAVIPP seeks to establish an…